Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 328 participants.
Also called NCT07460505
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 328 participants
- Registry
-
NCT07460505
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Singapore
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07460505. Randomized; triple masking; primary purpose treatment. Start 2026-05-01 (anticipated); primary completion 2031-04-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure
- Acronym
- MARVEL-HF
- Condition
- Heart Failure
- Condition
- OSA - Obstructive Sleep Apnea
- Intervention (Device)
- Mandibular advancement device
- Intervention (Device)
- Mandibular advancement device (Sham)
- Lead sponsor
- National University Hospital, Singapore
- Collaborator
- Alexandra Hospital
- Collaborator
- Ng Teng Fong General Hospital
Record details
- Record id
cardio:ct-nct07460505- Content hash
ecc1bca1b30c038c5c2e27ac36fe2b598b18a3a5c5c6b81a20a8f65e9bbd95ae